Search clinical trials for: Homologous Recombination Deficiency (HRD)
Total 9777 results
-
University Hospital, GhentMedriCompleted
-
The Netherlands Cancer InstituteActive, not recruitingBreast CancerNetherlands
-
Institut de Cancérologie de LorraineCompleted
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLCRecruitingMetastatic Pancreatic Ductal Adenocarcinoma | Homologous Recombination Deficiency (HRD)United States
-
AstraZenecaCompletedFallopian Tube CancerRussian Federation, Saudi Arabia, Qatar, Kuwait, Oman, United Arab Emirates
-
Xiaoxiang ChenNot yet recruitingOvarian Cancer | HRD | PARP InhibitorChina
-
Hubei Biological Medicine Industrial Technology...UnknownAdvanced Solid Tumors | HRD | BRCA MutationChina
-
Minnesota Medical Development, Inc.Ohio State University; University of KentuckyUnknown
-
Lei LiUnknownEpithelial Ovarian Cancer | BRCA1 Mutation | BRCA2 Mutation | Homologous Recombination Deficiency | Prognosis | ChineseChina
-
Vall d'Hebron Institute of OncologyRecruiting
-
University of ChicagoAstraZenecaRecruitingMesothelioma | Homologous Recombination DeficiencyUnited States
-
Sun Yat-sen UniversityRecruitingMetastatic Castration-resistant Prostate CancerChina
-
University of MalayaPfizer; Cancer Research Malaysia; Pantai Hospital Kuala Lumpur; Hospital Sultan...RecruitingTriple Negative Breast Cancer | HRD 100 Gene Expression HighMalaysia
-
Nordic Society of Gynaecological Oncology - Clinical...RecruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerDenmark
-
Lei LiRecruitingEpithelial Ovarian Cancer | Homologous Recombination Deficiency | Homologous Recombination Repair Gene Mutation | Drug Resistance | Overall Survival | Progression-free Survival | Poly(ADP-ribose) Polymerase InhibitorChina
-
German Breast GroupAstraZenecaCompletedBreast Cancer | Triple Negative Breast Neoplasms | HRpos Breast Neoplasms | BRCA 1 /2 and / or HRDGermany
-
Grupo Espanol Multidisciplinario del Cancer DigestivoMerk Sharp & Dohme España S.A.RecruitingMetastatic Colorectal CancerSpain
-
Lei LiUnknownEpithelial Ovarian Cancer | Homologous Recombination Deficiency | Prognosis | BRCA Mutation | Loss of Heterozygosity | Platinum ResistanceChina
-
West Cancer CenterRecruitingHomologous Recombination Deficient Solid TumorsUnited States
-
The Netherlands Cancer InstituteActive, not recruitingBreast CancerNetherlands, France
-
wang shusenRecruitingAdvanced HER2 Negative Breast Carcinoma HRD+Breast CancerChina
-
BeiGeneTerminatedMetastatic Castration-Resistant Prostate Cancer (mCRPC) | Homologous Recombination Deficiency (HRD)United States, Australia, Puerto Rico, Spain
-
Fudan UniversityNot yet recruitingHomologous Recombination Deficiency Alterations Metastatic Colorectal CancerChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingBreast Cancer | HER2-low Breast CancerChina
-
Tesaro, Inc.Gynecologic Oncology Group; European Network of Gynaecological Oncological... and other collaboratorsActive, not recruitingOvarian NeoplasmsUnited States, Spain, Finland, Czechia, Italy, Denmark, Germany, Belgium, Israel, Canada, Russian Federation, Sweden, United Kingdom, Poland, Ireland, Ukraine, France, Norway, Switzerland, Hungary
-
Alexander B Olawaiye, MDAstraZenecaRecruiting
-
Pamela MunsterNational Cancer Institute (NCI)Not yet recruitingBRCA1 Mutation | BRCA2 Mutation | PALB2 Gene Mutation | ATM Gene Mutation | BRCA Mutation | Checkpoint Kinase 2 Gene MutationUnited States
-
AstraZenecaActive, not recruitingSolid TumorsBelgium, United Kingdom, Switzerland, Australia
-
The Netherlands Cancer InstituteTerminated
-
Lei LiCompletedEpithelial Ovarian Cancer | BRCA1 Mutation | BRCA2 Mutation | Homologous Recombination Deficiency | Prognosis | Chinese | Homologous Recombination GenesChina
-
Fujian Cancer HospitalFujian Provincial HospitalNot yet recruiting
-
Tianjin Medical University Cancer Institute and...RecruitingAdvanced HER2 Negative Breast Carcinoma | HRD+Breast CancerChina
-
Walid Shaib, MDGlaxoSmithKline; Emory UniversityWithdrawnMetastatic Cancer | Cholangiocarcinoma | HRD
-
HvivoPfizerRecruiting
-
Senhwa Biosciences, Inc.RecruitingAdvanced Solid TumorUnited States, Canada
-
Xiaoxiang ChenNot yet recruitingOvarian Cancer | HRD | Platinum-sensitive Ovarian CancerChina
-
Xin WuRecruiting
-
AstraZenecaCompletedOvarian CancerCanada, Czechia, Poland, Romania, United States, Belgium, France, Russian Federation, United Kingdom, Israel, Spain, Germany, Austria, Netherlands, Australia, Estonia, Ukraine
-
HvivoPfizerCompletedInfluenza A H1N1United Kingdom
-
Translational Research Center for Medical Innovation...Japanese Gynecologic Oncology Group (JGOG); Department of Obstetrics and Gynecology... and other collaboratorsCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerJapan
-
Odessa National Medical UniversityUnknown
-
Tango Therapeutics, Inc.RecruitingBreast Cancer | Ovarian Cancer | Prostate Cancer | Pancreas Cancer | BRCA1 Mutation | BRCA-Mutated Ovarian Carcinoma | BRCA-Associated Breast Carcinoma | HRD Positive Advanced Ovarian CancerUnited States
-
Zhejiang Cancer HospitalJiangsu Hengrui Pharmaceutical Co., Ltd.Not yet recruitingFemale Breast Cancer Patients | Histopathologically Confirmed Advanced HR +/HER2-invasive Breast Cancer | HRD Positive Advanced Breast Cancer
-
AtlasMedx, IncorporatedActive, not recruitingBreast Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Homologous Recombination Deficiency | Advanced Malignant NeoplasmUnited States
-
Peter MacCallum Cancer Centre, AustraliaRecruiting
-
Peking University Cancer Hospital & InstituteRecruitingOvarian, Fallopian Tube and Primary Peritoneal CarcinomaChina
-
Mario Negri Institute for Pharmacological ResearchAstraZenecaRecruitingCarcinoma, Ovarian EpithelialItaly
-
AstraZenecaCompletedGastric CancerKorea, Republic of
-
pharmaand GmbHFoundation MedicineActive, not recruitingMetastatic Castration Resistant Prostate CancerUnited States, Canada, Spain, France, Australia, Ireland, Belgium, Denmark, United Kingdom, Germany, Israel, Italy